相似化合物
167216-17-3 61477-40-5 2867-59-6欧盟法规
C&L通报上下游产品
(-)-tert-butyl [(1S)-1-methylprop-2-en-1-yl]carbamate (S)-methyl 3-(tert-butyloxycarbonylamino)butyrate L-N-B°C-Ala tert-butyl dicarbonatedi-tert-butyl dicarbonate(3S)-1-bromo-t-butoxycarbonylbutan-3-ylamine (+)-tert-butyl [(R)-1-methyl-3-oxopropyl]carbamate (R)-3-amino-1-butanol 📜Boc-Dl-3-氨基乙酸置于lithium Aluminium Tetrahydride体系中,用 四氢呋喃 用作溶剂,化学反应 15.5H,以89%的收率获得n-(3-羟基-1-甲基丙基)-氨基甲酸叔丁酯
参考文献:To042 的生物等排修饰:电压门控钠通道有前途的使用依赖性抑制剂的合成和评价
标题:To042 的生物等排修饰:电压门控钠通道有前途的使用依赖性抑制剂的合成和评价
摘要:适当的神经活动:生物等排替代方法允许鉴定一种使用依赖性钠通道阻滞剂 ( 17A ),它具有低 P-糖蛋白介导的跨血脑屏障的主动转运和对 Hela 细胞的细胞保护作用.通过分子对接研究确定了参与结合 Hnav1.4 的目标残基.
Doi:10.1002/cmdc.202100496
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2912110000-甲醛
2915110000-甲酸 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-9994558-B2
优先权日:2013-09-20
标题 :Multicyclic compounds and methods of using same
发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).